Self-Administered Medication Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2017 to 2026

Published on : Nov-2017 | List of Tables : 136 | List of Figures : 84 | No. of Pages : 170 | Report Code : FACT328MR | Format :

Growing prevalence of chronic diseases has led to surge in the number of disabilities and cause of death. As prevalence of these diseases require frequent treatments, self-administered medication remains a cost-effective alternative. Increasing demand for self-treatment and healthcare management has led the self-administered medication market players to focus on developing medications and vaccinations that can be used for treatment at home.

self administered drugs market

According to Fact.MR, the global self-administered medication market is expected to represent a value of over US$ 100,000 Mn by the end of 2026.

Market Taxonomy

Region

Product Type

Route of Administration

Distribution Channel

North America

Insulin Pens

Oral

Hospital Pharmacies

Latin America

Opioid Pain Management

Subcutaneous

Retail Pharmacies

Europe

Prefilled Auto-injectors

Nasal

Online Pharmacies

Japan

Inhalers

Transdermal

 

APEJ

     

MEA

     

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Chronic Diseases to Impact Self-Administered Medication Market Growth

Prevalence of chronic diseases such as arthritis, asthma, inflammation and gastrointestinal diseases will impact growth of the self-administered medication market. As treatment of these diseases include vaccinations regularly, frequent visits to the hospital can be an expensive option. Moreover, growing need for treatment in the emergency conditions such as asthma and bronchitis has led growth of self-administered medication market. Immediate treatment of chronic disorders is expected to rev up demand for nasal sprays, eye drops, ear drops and tablets that provide quick relief to the patients. Bound to such factors, the self-administered medication market will witness significant growth.

Collaborations to Underscore Growth Lucrative Opportunities

Recent trend witnessed show that the self-administered medication market players are increasingly collaborating with the delivery device companies in order to underscore lucrative opportunities. For instance, Takeda has recently collaborated with Portal Instruments in order to develop a needle-free drug delivery device for delivering biologic medicines. The Portal devices delivers biologic drugs through pressurized liquid instead of through the needles. As manufacturers are increasingly focusing on developing improved drug delivery devices, the self-administered medication market is expected to witness significant growth.

On the other hand, various factors are impacting growth of self-administered drugs negatively. Risks of making errors during the dosage administration practices is expected to impact the self-administered medication market adversely. Moreover, lack of awareness regarding various drug administration devices will further affect the global self-administered medication market growth negatively. In addition, improper designing or directions to use the drug delivery devices could pose significant challenges to self-administered medication market growth. Bound to these factors, the self-administered medication market will witness declined growth during the forecast period.

Inhalers to Represent a Leading Segment

Growing prevalence of asthma has led to an upsurge in demand for inhalers in the self-administered medication market. On the basis of product type, the inhalers will witness robust sales in self-administered medication market, accounting for a value of over US$ 20,000 Mn by 2026-end. On the other hand, the insulin product type segment is expected to register a robust CAGR through 2026.

Nasal route of administration will remain preferred in self-administered medication market, recording a value of over US$ 10,000 Mn by the end of 2017. In contrary to this, the transdermal route of administration segment is expected to register the highest CAGR through 2026.

By distribution channel, hospital pharmacies will spearhead the self-administered medication market, accounting for a value of over US$ 20,000 Mn by the end of 2026. However, the online pharmacies distribution channel segment is expected to register a healthy CAGR through 2026.

Competition Tracking                                                        

Leading players operating in the self-administered medication market include Abbott Laboratories, Purdue Pharma LP, Sanofi S.A., Pfizer, Inc., Mylan N.V., Novartis AG, Amgen Inc. and others.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Growing prevalence of various chronic diseases is expected to fuel demand for the self-administered medication globally. In addition, increasing collaboration among manufacturers is expected to impact growth of the global market significantly. This Fact.MR report analyzes the expansion of global self-administered medication market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.

Scope

The scope of Fact.MR’s report is to analyze the global self-administered medication market for the forecast period 2017-2026 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global self-administered medication market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to self-administered medication.

Summary

The report commences with a brief information of the global self-administered medication market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global self-administered medication market.

Overview

The next section offers an overview of the global self-administered medication market. This comprises an introduction to the market, along with a standard definition of the product – self-administered medication. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global self-administered medication market, the report provides updates about market opportunities, which can benefit leading manufacturers of self-administered medication. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for self-administered medication manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global self-administered medication market. Product type, route of administration, distribution channel, and region are key segments that define the growth of the global market for self-administered medication. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.

The report’s last section comprises of the global self-administered medication market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global self-administered medication market.

Research Methodology

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,

  • Primary research
  • Secondary research
  • Trade research
  • Focused interviews
  • Social media analysis

Chapter 1 Global Outlook

Chapter 2 Global Self-Administered Drugs Market - Executive Summary

Chapter 3 Global Self-Administered Drugs Market Overview
3.1 Introduction
      3.1.1 Global Self-Administered Drugs Market Taxonomy
      3.1.2 Global Self-Administered Drugs Market Definition
3.2 Global Self-Administered Drugs Market Size (US$ Mn) and Forecast, 2012-2026
      3.2.1 Global Self-Administered Drugs Market Y-o-Y Growth
3.3 Global Self-Administered Drugs Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 Pricing Analysis
3.7 PESTLE Analysis
3.8 Product Life Cycle Analysis
3.9 Epidemiology
3.10 Key Regulations
3.11 Patents
3.12 List of Distributors
3.13 Key Participants Market Presence (Intensity Map) By Region

Chapter 4 Global Self-Administered Drugs Market Analysis and Forecast 2012-2026
4.1 Global Self-Administered Drugs Market Size and Forecast By Product Type, 2012-2026
      4.1.1 Insulin Pens Market Size and Forecast, 2012-2026
              4.1.1.1 Revenue (US$ Mn) Comparison, By Region
              4.1.1.2 Market Share Comparison, By Region
              4.1.1.3 Y-o-Y growth Comparison, By Region
      4.1.2 Opioid Pain Management Market Size and Forecast, 2012-2026
              4.1.2.1 Revenue (US$ Mn) Comparison, By Region
              4.1.2.2 Market Share Comparison, By Region
              4.1.2.3 Y-o-Y growth Comparison, By Region
      4.1.3 Prefilled Auto-injectors Market Size and Forecast, 2012-2026
              4.1.3.1 Revenue (US$ Mn) Comparison, By Region
              4.1.3.2 Market Share Comparison, By Region
              4.1.3.3 Y-o-Y growth Comparison, By Region
      4.1.4 Inhalers Market Size and Forecast, 2012-2026
              4.1.4.1 Revenue (US$ Mn) Comparison, By Region
              4.1.4.2 Market Share Comparison, By Region
              4.1.4.3 Y-o-Y growth Comparison, By Region
4.2 Global Self-Administered Drugs Market Size and Forecast By Route of Administration, 2012-2026
      4.2.1 Oral Market Size and Forecast, 2012-2026
              4.2.1.1 Revenue (US$ Mn) Comparison, By Region
              4.2.1.2 Market Share Comparison, By Region
              4.2.1.3 Y-o-Y growth Comparison, By Region
      4.2.2 Subcutaneous Market Size and Forecast, 2012-2026
              4.2.2.1 Revenue (US$ Mn) Comparison, By Region
              4.2.2.2 Market Share Comparison, By Region
              4.2.2.3 Y-o-Y growth Comparison, By Region
      4.2.3 Nasal Market Size and Forecast, 2012-2026
              4.2.3.1 Revenue (US$ Mn) Comparison, By Region
              4.2.3.2 Market Share Comparison, By Region
              4.2.3.3 Y-o-Y growth Comparison, By Region
      4.2.4 Transdermal Market Size and Forecast, 2012-2026
              4.2.4.1 Revenue (US$ Mn) Comparison, By Region
              4.2.4.2 Market Share Comparison, By Region
              4.2.4.3 Y-o-Y growth Comparison, By Region
4.3 Global Self-Administered Drugs Market Size and Forecast By Distribution Channel, 2012-2026
      4.3.1 Hospital Pharmacies Market Size and Forecast, 2012-2026
              4.3.1.1 Revenue (US$ Mn) Comparison, By Region
              4.3.1.2 Market Share Comparison, By Region
              4.3.1.3 Y-o-Y growth Comparison, By Region
      4.3.2 Retail Pharmacies Market Size and Forecast, 2012-2026
              4.3.2.1 Revenue (US$ Mn) Comparison, By Region
              4.3.2.2 Market Share Comparison, By Region
              4.3.2.3 Y-o-Y growth Comparison, By Region
      4.3.3 Online Pharmacies Market Size and Forecast, 2012-2026
              4.3.3.1 Revenue (US$ Mn) Comparison, By Region
              4.3.3.2 Market Share Comparison, By Region
              4.3.3.3 Y-o-Y growth Comparison, By Region

Chapter 5 North America Self-Administered Drugs Market Size and Forecast, 2012-2026
5.1 North America Market Outlook
5.2 Revenue (US$ Mn) Comparison, By Country
5.3 Revenue (US$ Mn) Comparison, By Product Type
5.4 Revenue (US$ Mn) Comparison, By Route of Administration
5.5 Revenue (US$ Mn) Comparison, By Distribution Channel

Chapter 6 Latin America Self-Administered Drugs Market Size and Forecast, 2012-2026
6.1 Latin America Market Outlook
6.2 Revenue (US$ Mn) Comparison, By Country
6.3 Revenue (US$ Mn) Comparison, By Product Type
6.4 Revenue (US$ Mn) Comparison, By Route of Administration
6.5 Revenue (US$ Mn) Comparison, By Distribution Channel

Chapter 7 Europe Self-Administered Drugs Market Size and Forecast, 2012-2026
7.1 Europe Market Outlook
7.2 Revenue (US$ Mn) Comparison, By Country
7.3 Revenue (US$ Mn) Comparison, By Product Type
7.4 Revenue (US$ Mn) Comparison, By Route of Administration
7.5 Revenue (US$ Mn) Comparison, By Distribution Channel

Chapter 8 Japan Self-Administered Drugs Market Size and Forecast, 2012-2026
8.1 Japan Market Outlook
8.2 Revenue (US$ Mn) Comparison, By Country
8.3 Revenue (US$ Mn) Comparison, By Product Type
8.4 Revenue (US$ Mn) Comparison, By Route of Administration
8.5 Revenue (US$ Mn) Comparison, By Distribution Channel

Chapter 9 APEJ Self-Administered Drugs Market Size and Forecast, 2012-2026
9.1 APEJ Market Outlook
9.2 Revenue (US$ Mn) Comparison, By Country
9.3 Revenue (US$ Mn) Comparison, By Product Type
9.4 Revenue (US$ Mn) Comparison, By Route of Administration
9.5 Revenue (US$ Mn) Comparison, By Distribution Channel

Chapter 10 MEA Self-Administered Drugs Market Size and Forecast, 2012-2026
10.1 MEA Market Outlook
10.2 Revenue (US$ Mn) Comparison, By Country
10.3 Revenue (US$ Mn) Comparison, By Product Type
10.4 Revenue (US$ Mn) Comparison, By Route of Administration
10.5 Revenue (US$ Mn) Comparison, By Distribution Channel

Chapter 11 Global Self-Administered Drugs Market – Competitive Landscape and Company Profiles
11.1 Global Self-Administered Drugs Market – Company Share Analysis
11.2 Global Self-Administered Drugs Market – Competitive Landscape
11.3 Global Self-Administered Drugs Market – Company Profiles
      11.3.1 Abbott Laboratories
              11.3.1.1 Company Overview
              11.3.1.2 Product Overview
              11.3.1.3 Key Financials
              11.3.1.4 Key Developments
              11.3.1.5 SWOT Analysis
      11.3.2 Novartis AG
              11.3.2.1 Company Overview
              11.3.2.2 Product Overview
              11.3.2.3 Key Financials
              11.3.2.4 SWOT Analysis
      11.3.3 Mylan N.V.
              11.3.3.1 Company Overview
              11.3.3.2 Product Overview
              11.3.3.3 Key Financials
              11.3.3.4 Key Developments
              11.3.3.5 SWOT Analysis
      11.3.4 Becton, Dickinson and Company
              11.3.4.1 Company Overview
              11.3.4.2 Product Overview
              11.3.4.3 Key Financials
              11.3.4.4 SWOT Analysis
      11.3.5 Takeda Pharmaceutical Company Limited
              11.3.5.1 Company Overview
              11.3.5.2 Product Overview
              11.3.5.3 Key Financials
              11.3.5.4 Key Developments
              11.3.5.5 SWOT Analysis
      11.3.6 Amgen Inc.
              11.3.6.1 Company Overview
              11.3.6.2 Product Overview
              11.3.6.3 Key Financials
              11.3.6.4 SWOT Analysis
      11.3.7 Pfizer Inc.
              11.3.7.1 Company Overview
              11.3.7.2 Product Overview
              11.3.7.3 Key Financials
              11.3.7.4 Key Developments
              11.3.7.5 SWOT Analysis
      11.3.8 Sanofi
              11.3.8.1 Company Overview
              11.3.8.2 Product Overview
              11.3.8.3 Key Financials
              11.3.8.4 Key Developments
              11.3.8.5 SWOT Analysis
      11.3.9 Antares Pharma, Inc.
              11.3.9.1 Company Overview
              11.3.9.2 Product Overview
              11.3.9.3 Key Financials
              11.3.9.4 Key Developments
              11.3.9.5 SWOT Analysis
      11.3.10 Purdue Pharma L.P.
              11.3.10.1 Company Overview
              11.3.10.2 Product Overview
              11.3.10.3 Key Developments
              11.3.10.4 SWOT Analysis
11.4 Key Takeaways – Self-Administered Drugs Market

Chapter 12 Fact.MR Research Methodology

Chapter 13 Disclaimer

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Self-Administered Medication Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2017 to 2026